Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
25%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HRTS
44
HOLDINGS
26%
ALSO IN THNR
THNR
19
HOLDINGS
61%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 11.3% | 8.9% | 8.9% | |
| MERCK & CO. INC. | 4.0% | 5.1% | 4.0% | |
| ASTRAZENECA PLC | 3.1% | 3.9% | 3.1% | |
| ABBVIE INC | 2.3% | 5.0% | 2.3% | |
| AMGEN INC | 2.2% | 5.4% | 2.2% | |
HRTS Overweight Relative to THNR
| UNITEDHEALTH GROUP INC | 5.2% | |
| THERMO FISHER SCIENTIFIC INC | 5.1% | |
| NOVO NORDISK A/S-B | 5.0% | |
| ROCHE HOLDINGS LTD-SPONS ADR | 3.9% | |
| JOHNSON & JOHNSON | 3.8% | |
| REVOLUTION MEDICINES, INC. | 3.6% | |
| ABBOTT LABORATORIES | 3.1% | |
| CYTOKINETICS INC | 3.0% | |
| GILEAD SCIENCES INC | 2.9% | |
| NOVARTIS AG | 2.9% |
HRTS Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -9.1% | |
| INNOVENT BIOLOGICS, INC. | -5.8% | |
| CHINA PHARMACEUTICAL GROUP | -5.4% | |
| REGENERON PHARMACEUTICALS | -4.8% | |
| PFIZER INC | -4.7% | |
| SCHOLAR ROCK HOLDING CORP. | -4.7% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -4.4% | |
| HIMS & HERS HEALTH, INC. CLASS A | -4.4% | |
| VIKING THERAPEUTICS, INC. | -4.0% | |
| ZEALAND PHARMA A/S | -3.3% |